Correlating magnetic resonance imaging markers of axonal injury and demyelination in motor impairment secondary to stroke and multiple sclerosis

Magnetic Resonance Imaging

Volumn 18, Issue 4, 2000, Pages 369-378

  Pendleburyab, Sarah T ^a,b   Lee, Martin A ^b   Blamire, Andrew M ^b   Styles, Peter ^b   Matthews, Paul M ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Axonal injury; Demyelination; Multiple sclerosis; Stroke

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; DEMYELINATING DISEASE; DEMYELINATION; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NERVE CELL LESION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STROKE;

ADULT; AGED; ASPARTIC ACID; AXONS; CEREBROVASCULAR ACCIDENT; FEMALE; FUNCTIONAL LATERALITY; HUMANS; INTERNAL CAPSULE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOVEMENT DISORDERS; MULTIPLE SCLEROSIS; MYELIN SHEATH;

EID: 0033995856     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(00)00115-6     Document Type: Article

References (43)

1. Miller D.H. Magnetic resonance in monitoring the treatment of multiple sclerosis. Ann Neurol. 36:(Suppl):1994;S91-S94.
2. Saver J.L., Johnston K.C., Homer D., et al. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke. 30:1999;293-298.
3. Urenjak J., Williams S.R., Gadian D.G., Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem. 59:1992;55-61.
4. Bruhn H., Frahm J., Gyngell M.L., Merboldt K.D., Hanicke W., Sauter R. Cerebral metabolism in man after acute stroke new observations using localised proton NMR spectroscopy . Magn Reson Med. 9:1988;126-131.
5. Graham G.D., Blamire A.M., Rothman D.L., et al. Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study. Stroke. 24:1993;1891-1896.
6. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. 1991;41:1251-6 [published erratum appears in Neurology 1991 Nov;41(11):1828].
7. Matthews PM, Francis G, Antel J, Arnold DL. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. 1991;41:1251-6 [published erratum appears in Neurology 1991 Nov;41(11):1828].
8. Davie C.A., Hawkins C.P., Barker G.J., et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
9. Fu L., Matthews P.M., De S.N., et al. Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain. 121:1998;103-113.
10. 1H spectroscopic imaging. Ann Neurol. 36:1994;157-165.
11. De Stefano N., Matthews P.M., Fu L., et al. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain. 121:1998;1469-1477.
12. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;118:1583-92 [published erratum appears in Brain 1996 Aug;119(Pt 4):1415].
13. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;118:1583-92 [published erratum appears in Brain 1996 Aug;119(Pt 4):1415].
14. Pendlebury S.T., Blamire A.M., Lee M.A., Styles P., Matthews P.M. Axonal injury in the internal capsule correlates with motor impairment after stroke. Stroke. 30:1999;956-962.
15. Lee M.A., Blamire A.M., Pendlebury S.T., et al. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch Neurol. 57:2000;65-70.
16. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-91. [published erratum appears in Radiology 1992;183:878].
17. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-91. [published erratum appears in Radiology 1992;183:878].
18. Mehta R.C., Pike G.B., Enzmann D.R. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. AJNR AM J Neuroradiol. 17:1996;1051-1055.
19. Thorpe J.W., Barker G.J., Jones S.J., et al. Magnetisation transfer ratios and transverse magnetisation decay curves in optic neuritis correlation with clinical findings and electrophysiology . J Neurol Neurosurg Psychiatry. 59:1995;487-492.
20. Dousset V., Brochet B., Vital A., et al. Lysolecithin-induced demyelination in primates preliminary in vivo study with MR and magnetization transfer . AJNR Am J Neuroradiol. 16:1995;225-231.
21. Silver N.C., Barker G.J., MacManus D.G., Miller D.H., Thorpe J.W., Howard R.S. Decreased magnetisation transfer ratio due to demyelination a case of central pontine myelinolysis (letter) . J Neurol Neurosurg Psychiatry. 61:1996;208-209.
22. Hanyn H., Imon Y., Sakurai H., et al. Diffusion-weighted magnetic resonance and MY magnetization transfer imaging in the assessment of ischemic human stroke. Intern Med. 37:1998;360-365.
23. Tomiak M.M., Rosenblum J.D., Prager J.M., Metz C.E. Magnetization transfer a potential method to determine the age of multiple sclerosis lesions . AJNR Am J Neuroradiol. 15:1994;1569-1574.
24. Loevner L.A., Grossman R.I., Cohen J.A., Lexa F.J., Kessler D., Kolson D.L. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis assessment with magnetization-transfer measurements . Radiology. 196:1995;511-515.
25. Filippi M., Campi A., Dousset V., et al. A magnetization transfer imaging study of normal-appearing white matter multiple sclerosis. Neurology. 45:1995;478-482.
26. Lexa F.J., Grossman R.I., Rosenquist A.C. Detection of early axonal degeneration in the mammalian central nervous system by magnetization transfer techniques in magnetic resonance imaging. Ann N Y Acad Sci. 679:1993;336-340.
27. Hatano S. Experience from a multicentre stroke register a preliminary report . Bull World Health Organ. 54:1976;541-553.
28. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 508:1987;333-348.
29. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol. 30:1985;341-344.
30. Demeurisse G., Demol O., Robaye E. Motor evaluation in vascular hemiplegia. Eur Neurol. 19:1980;382-389.
31. Sharpless JW. The nine hole peg test of finger hand co-ordination for the hemiplegic patient. In: Mossman, editor. A Problem-Orientated Approach to Stroke Rehabilitation. Springfield: Charles CT Thomas, 1982. p. 420-3.
32. Sunderland A., Tinson D., Bradley L., Hewer R.L. Arm function after stroke. An evaluation of grip strength as a measure of recovery and a prognostic indicator. J Neurol Neurosurg Psychiatry. 52:1989;1267-1272.
33. Salmaso D., Longoni A.M. Problems in the assessment of hand preference. Cortex. 21:1985;533-549.
34. Griffin J.W., George R., Lobato C., Tyor W.R., Yan L.C., Glass J.D. Macrophage responses and myelin clearance during Wallerian degeneration relevance to immune-mediated demyelination . J Neuroimmunol. 40:1992;153-165.
35. Barron K.D., Mean E.D., Larsen E. Ultrastructure or retrograde degeneration in thalamus of rat. J Neuropathol Exp Neurol. 32:1973;218-244.
36. George R., Griffin J.W. Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system the dorsal radiculotomy model . Exp Neurol. 129:1994;225-236.
37. Gideon P., Henriksen O., Sperling B., et al. Early time course of N-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke. A proton magnetic resonance spectroscopy study. Stroke. 23:1992;1566-1572.
38. Kimura H., Grossman R.I., Lenkinski R.E., Gonzalez S.F. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis correlative findings of active versus irreversible plaque disease . AJNR Am J Neuroradiol. 17:1996;1539-1547.
39. Hiehle J.F.J., Lenkinski R.E., Grossman R.I., et al. Correlation of spectroscopy and magnetization transfer imaging in the evaluation of demyelinating lesions and normal appearing white matter in multiple sclerosis. Magn Reson Med. 32:1994;285-293.
40. Gass A., Barker G.J., Kidd D., et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol. 36:1994;62-67.
41. Silver N.C., Barker G.J., MacManus D.G., Tofts P.S., Miller D.H. Magnetisation transfer ratio of normal brain white matter a normative database spanning four decades of life . J Neurol Neurosurg Psychiatry. 62:1997;223-228.
42. Charles H.C., Lazeyras F., Krishnan K.R., et al. Proton spectroscopy of human brain effects of age and sex . Prog Neuropsychopharmacol Biol Psychiatry. 18:1994;995-1004.
43. Christiansen P., Toft P., Larsson H.B., Stubgaard M., Henriksen O. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging. 11:1993;799-806.